Search research articles
Contact Us
Filters
Showing results (1251-1260 of 1,275) with videos related to
Page
of 128
Sort By:
Journal of the American College of Cardiology
|
September 2, 2025
Effect of Vericiguat on Worsening Heart Failure in Compensated Outpatients with HFrEF: Insights from VICTOR
Faiez Zannad, Yogesh N V Reddy, Irina Barash, et al.
European Journal of Heart Failure
|
April 12, 2023
Geographic differences in patients with acute myocardial infarction in the PARADISE-MI trial
Jawad H Butt, Brian L Claggett, Zi M Miao, et al.
American Journal of Human Genetics
|
April 30, 2026
Navigating data sharing in research
Anna C F Lewis, Ellen W Clayton, Hana Bangash, et al.
Public Health Genomics
|
May 29, 2026
Imagining Genomics and Population Health in 2050: Anticipating Future Research, Policy, and Governance Needs
Bartha Maria Knoppers, Yann Joly, Ma Apos N H Zawati, et al.
European Heart Journal
|
August 30, 2025
Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial
Javed Butler, Francesco Fioretti, Ciaran J McMullan, et al.
JAMA
|
August 14, 2024
Edetate Disodium-Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes: TACT2 Randomized Clinical Trial
Gervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, et al.
Lancet (London, England)
|
September 2, 2025
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial
Javed Butler, Ciaran J McMullan, Kevin J Anstrom, et al.
American Journal of Human Genetics
|
April 30, 2024
Managing differential performance of polygenic risk scores across groups: Real-world experience of the eMERGE Network
Anna C F Lewis, Rex L Chisholm, John J Connolly, et al.
American Journal of Obstetrics and Gynecology
|
August 12, 2020
Prospective, randomized, double-blind, placebo-controlled evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Michael J Paidas, Allan T N Tita, George A Macones, et al.
The New England Journal of Medicine
|
November 10, 2021
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction
Marc A Pfeffer, Brian Claggett, Eldrin F Lewis, et al.
Page
of 128
Search research articles
Search
Showing results (1251-1260 of 1,275) with videos related to
Sort By:
Page
of 128
Journal of the American College of Cardiology
|
September 2, 2025
Effect of Vericiguat on Worsening Heart Failure in Compensated Outpatients with HFrEF: Insights from VICTOR
Faiez Zannad, Yogesh N V Reddy, Irina Barash, et al.
European Journal of Heart Failure
|
April 12, 2023
Geographic differences in patients with acute myocardial infarction in the PARADISE-MI trial
Jawad H Butt, Brian L Claggett, Zi M Miao, et al.
American Journal of Human Genetics
|
April 30, 2026
Navigating data sharing in research
Anna C F Lewis, Ellen W Clayton, Hana Bangash, et al.
Public Health Genomics
|
May 29, 2026
Imagining Genomics and Population Health in 2050: Anticipating Future Research, Policy, and Governance Needs
Bartha Maria Knoppers, Yann Joly, Ma Apos N H Zawati, et al.
European Heart Journal
|
August 30, 2025
Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial
Javed Butler, Francesco Fioretti, Ciaran J McMullan, et al.
JAMA
|
August 14, 2024
Edetate Disodium-Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes: TACT2 Randomized Clinical Trial
Gervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, et al.
Lancet (London, England)
|
September 2, 2025
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial
Javed Butler, Ciaran J McMullan, Kevin J Anstrom, et al.
American Journal of Human Genetics
|
April 30, 2024
Managing differential performance of polygenic risk scores across groups: Real-world experience of the eMERGE Network
Anna C F Lewis, Rex L Chisholm, John J Connolly, et al.
American Journal of Obstetrics and Gynecology
|
August 12, 2020
Prospective, randomized, double-blind, placebo-controlled evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Michael J Paidas, Allan T N Tita, George A Macones, et al.
The New England Journal of Medicine
|
November 10, 2021
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction
Marc A Pfeffer, Brian Claggett, Eldrin F Lewis, et al.
Page
of 128